Moreover, ERK5 can enhance the production of interleukin-6 (IL-6), aiding lung cancer cells in evading anti-tumor immune responses [57], and can also amplify the DNA damage response, increasing lung cancer cells’ resistance to radiotherapy [56]. This evidence concerns the gene MAPK7 and lung cancer.